Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $169,000 | 64 | 49.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $106,722 | 35 | 31.3% |
| Travel and Lodging | $57,493 | 364 | 16.9% |
| Food and Beverage | $7,372 | 88 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $206,207 | 354 | $0 (2018) |
| GENZYME CORPORATION | $133,510 | 194 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $869.71 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $58.33 | 1 | Teva Pharmaceuticals USA, Inc. ($58.33) |
| 2017 | $340,529 | 550 | Teva Pharmaceuticals USA, Inc. ($206,149) |
All Payment Transactions
551 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/12/2018 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Food and Beverage | In-kind items and services | $58.33 | General |
| Category: Central Nervous System | ||||||
| 12/20/2017 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Travel and Lodging | In-kind items and services | $160.50 | General |
| Category: Central Nervous System | ||||||
| 12/14/2017 | GENZYME CORPORATION | AUBAGIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,420.00 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/14/2017 | GENZYME CORPORATION | AUBAGIO (Drug) | Travel and Lodging | In-kind items and services | $266.97 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/14/2017 | GENZYME CORPORATION | AUBAGIO (Drug) | Travel and Lodging | In-kind items and services | $117.37 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/14/2017 | GENZYME CORPORATION | AUBAGIO (Drug) | Travel and Lodging | In-kind items and services | $97.49 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/14/2017 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/13/2017 | GENZYME CORPORATION | LEMTRADA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,420.00 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/13/2017 | GENZYME CORPORATION | LEMTRADA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,420.00 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/13/2017 | GENZYME CORPORATION | LEMTRADA (Drug) | Travel and Lodging | In-kind items and services | $266.97 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/13/2017 | GENZYME CORPORATION | LEMTRADA (Drug) | Travel and Lodging | In-kind items and services | $266.97 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/13/2017 | GENZYME CORPORATION | LEMTRADA (Drug) | Food and Beverage | In-kind items and services | $123.73 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/13/2017 | GENZYME CORPORATION | LEMTRADA (Drug) | Travel and Lodging | In-kind items and services | $117.37 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/13/2017 | GENZYME CORPORATION | LEMTRADA (Drug) | Travel and Lodging | In-kind items and services | $117.37 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/13/2017 | GENZYME CORPORATION | LEMTRADA (Drug) | Travel and Lodging | In-kind items and services | $97.49 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/13/2017 | GENZYME CORPORATION | LEMTRADA (Drug) | Travel and Lodging | In-kind items and services | $97.49 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/13/2017 | GENZYME CORPORATION | LEMTRADA (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/12/2017 | GENZYME CORPORATION | AUBAGIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,082.00 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/12/2017 | GENZYME CORPORATION | AUBAGIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,178.00 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/12/2017 | GENZYME CORPORATION | AUBAGIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,178.00 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/12/2017 | GENZYME CORPORATION | AUBAGIO (Drug) | Travel and Lodging | In-kind items and services | $269.84 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/12/2017 | GENZYME CORPORATION | AUBAGIO (Drug) | Travel and Lodging | In-kind items and services | $269.64 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/12/2017 | GENZYME CORPORATION | AUBAGIO (Drug) | Travel and Lodging | In-kind items and services | $266.97 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/12/2017 | GENZYME CORPORATION | AUBAGIO (Drug) | Travel and Lodging | In-kind items and services | $117.41 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/12/2017 | GENZYME CORPORATION | AUBAGIO (Drug) | Travel and Lodging | In-kind items and services | $117.37 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
About Dr. Lloyd Kasper, MD
Dr. Lloyd Kasper, MD is a Neurology healthcare provider based in Lebanon, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942386982.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lloyd Kasper, MD has received a total of $340,587 in payments from pharmaceutical and medical device companies, with $58.33 received in 2018. These payments were reported across 551 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($169,000).
Practice Information
- Specialty Neurology
- Location Lebanon, NH
- Active Since 10/31/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1942386982
Products in Payments
- COPAXONE (Drug) $206,207
- LEMTRADA (Drug) $77,334
- AUBAGIO (Drug) $56,083
- Betaseron (Drug) $869.71
- MS DISEASE STATE (Drug) $93.13
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Lebanon
Dr. Mark Janicki, Md, Faan, MD, FAAN
Neurology — Payments: $962,028
Donald Kolva, M.d, M.D
Neurology — Payments: $137,359
Dr. Oliver Phillips, Md, MD
Neurology — Payments: $48,807
Dr. Jianhui Zhang, M.d, M.D
Neurology — Payments: $11,709
Francis Benz, Md, MD
Neurology — Payments: $11,449
Dr. Stephen Lee, M.d.,Ph.d, M.D.,PH.D
Neurology — Payments: $6,997